Litcius/Paper detail

Mirikizumab: First Approval

Susan J. Keam

2023Drugs21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineUlcerative colitisInternal medicineInvestigational DrugsOrphan drugPharmacotherapyMaintenance therapyIntensive care medicineDiseaseClinical trialChemotherapyBioinformaticsBiologyInflammatory Bowel DiseaseMicroscopic ColitisImmunodeficiency and Autoimmune Disorders
Mirikizumab: First Approval | Litcius